Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Dolgencorp Inc
WARNING LETTER
•Dolgencorp Inc

Dolgencorp Inc – FDA Warning Letter

Record Details

The FDA issued a Warning Letter to Dolgencorp, Inc. regarding their drug product, "Rexall Earache Relief Drops," following a review of its labeling and marketing information. The product is deemed in violation of the Federal Food, Drug, and Cosmetic Act (the Act), specifically misbranded under Sections 502 and 503, and in violation of Section 301.

The product's labeling, including its name, website claims, and statements about "Mercurius Solubilis" and pain relief, establish it as a drug intended for disease treatment or to affect body function. Despite being marketed as an over-the-counter (OTC) drug, "Rexall Earache Relief Drops" is classified as a prescription drug under Section 503(b)(1) of the Act. This is because ear pain requires diagnosis and treatment by a physician, and is not a recognized OTC indication in the final monograph for topical otic drug products (21 CFR 344) or any approved OTC new drug application.

Consequently, the product is misbranded under Section 503(b)(4) for failing to bear the "Rx only" symbol. It is also misbranded under Section 502(f)(1) due to inadequate directions for use, as the indication for ear pain is not appropriate for OTC use. Furthermore, the labeling is considered false or misleading under Section 502(a)

Company
Dolgencorp Inc
Office
New Orleans District Office
People
  • Patricia K. Schafer
  • Mark W. Rivero (Compliance Officer)
View Company Profile

ID · 47a739b7-20dd-4fd9-9a4f-5ad91b58261a

Violation Codes10
21 U.S.C. 35221 U.S.C. 35321 U.S.C. 33121 U.S.C. 321(g)(1)(B)21 U.S.C. 321(g)(1)(C)21 U.S.C. 353(b)(1)21 U.S.C. 353(b)(4)21 U.S.C. 352(f)(1)21 CFR 201.521 U.S.C. 352(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Dolgencorp Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.